期刊文献+

非小细胞肺癌恶性胸腔积液的局部辨证分型分布及生存期差异研究 被引量:2

Study on the distribution of Chinese medicine syndrome types by local differentiation and their differences of the survival time in NSCLC with malignant pleural effusion
原文传递
导出
摘要 目的:分析非小细胞肺癌合并恶性胸腔积液患者证型分布及生存期差异,为应用局部辨证法指导非小细胞肺癌合并恶性胸腔积液的治疗提供理论基础。方法:通过回顾性研究2015年1月1日至2018年3月31日就诊于北京中医药大学东方医院肿瘤科住院病房的非小细胞肺癌合并恶性胸腔积液102例患者进行局部辨证分型,记录患者性别、年龄、发病部位以及生存期,比较湿热毒证、寒湿毒症两种证型间患者各项资料的差异。结果:非小细胞肺癌合并恶性胸腔积液患者中寒湿毒证(70.6%,72/102)患者多于湿热毒证(29.4%,30/102),两种证型患者性别、年龄、发病部位无显著性差异,寒湿毒证平均生存期为9.46个月、湿热毒证为5.21个月,差异有统计学意义(P<0.05)。结论:寒湿毒证是恶性胸腔积液常见证型,且生存期长于湿热毒型。 Objective:To analyze the difference between Chinese medicine syndromes and the survival time in patients with non-small cell lung cancer complicated with malignant pleural effusion,and to provide a theoretical basis for differentiation of local syndromes in the treatment of malignant pleural effusion and improve the clinical efficacy.Methods:A retrospective study including 102 patients from January 1,2015 to March 31,2018 in Dongfang Hospital,Beijing University of Chinese Medicine oncology department ward was designed to identify the differences of distribution of the Chinese medicine syndrome and the gender,age,location and survival time of NSCLC with MPE.Results:Among patients with NSCLC and malignant pleural effusion,cold and damp toxin syndrome(70.6%,72/102)is more than damp and heat toxin syndrome(29.4%,30/102).There is no difference in gender,age,location between the two syndrome types of patients.The survival time of patients with the two syndromes was:cold and damp toxin syndrome(9.46 months),damp and heat toxin syndrome(5.21 months),and the difference in survival time was statistically significant(P<0.05).Conclusion:In NSCLC with MPE,the cold-dampness toxicity is more common,and the survival time is longer than the damp-heat toxicity type.
作者 郑俊超 左明焕 王一同 蒋璐剑 吴娜 周琴 ZHENG Jun-chao;ZUO Ming-huan;WANG Yi-tong;JIANG Lu-jian;WU Na;ZHOU Qin(Beingjing University of Chinese Medicine,Beijing 100029,China;Dongfang Hospital Beijing University of Chinese Medicine,Beijing 100078,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2021年第2期1098-1101,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家自然科学基金项目(No.81373832) 北京中医药大学研究生校级课题(No.2019-JYBXS-200) 北京中医药大学青年教师课题(No.2017-JYB-JS-113)。
关键词 非小细胞肺癌 恶性胸腔积液 局部辨证 寒热辨证 Non-small cell lung cancer Malignant Pleural Effusion Local differentiation Differentiation of cold and heat
  • 相关文献

参考文献4

二级参考文献53

  • 1赵俊生,李海霞.华蟾素加复方樟柳碱局部注射治疗亨特氏面瘫1例[J].中医耳鼻喉科学研究,2013(2):52-52. 被引量:2
  • 2朱晓燕(综述),刘鲁明(审校).华蟾素注射液及其活性成份抗肿瘤机制的研究进展[J].世界肿瘤杂志,2006,5(4):272-275. 被引量:20
  • 3童朝辉,王臻,王辰.内科胸腔镜技术及其临床应用[J].中华结核和呼吸杂志,2007,30(3):220-222. 被引量:86
  • 4Light RW.Clinical practice.Pleural effusion[J].N Engl J Med,2002,346:1971-1977.
  • 5Burrows CM,Mathews WC,Colt HG.Predicting survival in patients with recurrent symptomatic malignant pleural effusions:an assessment of the prognostic values of physiologic,morphologic,and quality of life measures of extent of disease[J].Chest,2000,117:73-78.
  • 6Roberts ME,Neville E,Berrisford RG,et al.Management of a malignant pleural effusion:British Thoracic Society Pleural Disease Guideline 2010[J].Thorax,2010,65 Suppl 2:ii32-40.
  • 7Hsu C.Cytologic detection of malignancy in pleural effusion:a review of 5,255 samples from 3,811 patients[J].Diagn Cytopathol,1987,3:8-12.
  • 8Salyer WR,Eggleston JC,Erozan YS.Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura[J].Chest,1975,67:536-539.
  • 9Harris R J,Kavuru MS,Rice TW,et al.The diagnostic and therapeutic utility of thoracoscopy.A review[J].Chest,1995,108:828-841.
  • 10Kim BS,Kim IJ,Kim SJ,et al.Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients[J].Onkologie,2011,34:298-303.

共引文献239

同被引文献68

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部